Senior Product Security Engineer
Goodleap- Full Time
- Senior (5 to 8 years), Mid-level (3 to 4 years)
Illumina is dedicated to expanding access to genomic technology to realize health equity for billions of people worldwide. Our work enables life-changing discoveries that transform human health through early disease detection, diagnosis, and new treatment options. Working at Illumina means being part of something bigger than yourself, with opportunities to make a difference in every role.
The Product Security Team is seeking a talented Sr. Product Security Engineer to strengthen our business. This role requires experience in Product Security and software development. You will lead pre-market and post-market security initiatives and solutions for Illumina's medical instruments and connected software before customer release.
As a Product Security Architect, you will be critical in ensuring the security of our physical medical devices and software solutions development. You will define, identify, evaluate, and maintain controls, providing visibility into the health and security of our products. You will collaborate closely with engineering, development, and technology groups to define and maintain medical device security and lead changes to ensure a secure posture for Illumina products throughout their lifecycle. You will introduce security controls, processes, and testing throughout the entire product SDLC, from hardware selection to decommissioning. You are highly motivated to integrate security capabilities into continuous release planning and execution for all Illumina products.
Supports genomics startups through funding and resources
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.